Despite the hope created by the recent introduction of protease inhibitors, patients with AIDS are still dying in large numbers,and palliative care/quality of life issues in patients with advanced AIDS remains an important area of clinical investigation. Perhaps the most compelling and clinically relevant issue in palliative care today concerns desire for death and physician assisted suicide (PAS). Despite the recent Supreme Court decisions, the issue of whether or not to legalize PAS will continue to be actively debated in many state legislatures. It is anticipated that several states will legalize PAS, and guidelines are being developed for its use that involve psychiatric evaluation as an important component. There have been several recent studies of patients with cancer or AIDS, including one on interest in PAS among ambulatory patients with AIDS published by the investigator's research group, demonstrating that depression plays an important and perhaps central role in some patients' desire for death or interest in PAS. With only one exception, these studies have failed to directly assess/measure desire for death among terminally ill patients,and no research to date has attempted to answer the question of whether treatment for depression has a significant impact on patients' desire for death. This project's overall aim is to describe desire for death among patients with end-stage AIDS, determine the correlates of desire for death, and assess the impact of treatment for major depression on patients' desire for death. Specifically, the investigators will assess the prevalence, severity, consistency over time (8 weeks), and medical/psychosocial correlated of desire for death among terminally ill AIDS patients, as well as the relationship between desire for death and a clinical diagnosis of Major Depressive Episode. Desire for death will be monitored over an 8-week period in a group of patients who receive a standardized pharmacological treatment for depression. This study aims to provide the first direct evaluation of the desire for death among terminally ill patients with AIDS, and will provide data on the critical issue of whether or not treatment for depression influences patients' desire for death.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH057629-04
Application #
6392286
Study Section
Psychobiological, Biological, and Neurosciences Subcommittee (MHAI)
Program Officer
Gordon, Christopher M
Project Start
1998-07-01
Project End
2003-06-30
Budget Start
2001-07-01
Budget End
2003-06-30
Support Year
4
Fiscal Year
2001
Total Cost
$364,999
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Kolva, Elissa; Rosenfeld, Barry; Liu, Ying et al. (2017) Using item response theory (IRT) to reduce patient burden when assessing desire for hastened death. Psychol Assess 29:349-353
Atkinson, Thomas M; Rosenfeld, Barry D; Sit, Laura et al. (2011) Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage 41:558-65
Breitbart, William; Rosenfeld, Barry; Gibson, Christopher et al. (2010) Impact of treatment for depression on desire for hastened death in patients with advanced AIDS. Psychosomatics 51:98-105
Rosenfeld, Barry; Breitbart, William; Gibson, Christopher et al. (2006) Desire for hastened death among patients with advanced AIDS. Psychosomatics 47:504-12
Rosenfeld, Barry; Gibson, Christopher; Kramer, Michael et al. (2004) Hopelessness and terminal illness: the construct of hopelessness in patients with advanced AIDS. Palliat Support Care 2:43-53
Pessin, Hayley; Rosenfeld, Barry; Burton, Leslie et al. (2003) The role of cognitive impairment in desire for hastened death: a study of patients with advanced AIDS. Gen Hosp Psychiatry 25:194-9